Public signalCompany raiseAuto-indexed · Unverified

Immunophotonics, Inc. raised $10.1M

Immunophotonics, Inc.· St. Louis, US· Pharmaceuticals· Filed Sep 4, 2026

Immunophotonics, Inc. reported raising capital. Based in St. Louis, MISSOURI, US. First sale reported 2025-07-14. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$10.1M
Confidence90%
Raised
$10.1M
Investors
45
Jurisdiction
DELAWARE

On the record

Location
St. Louis, US
Sector
Pharmaceuticals
Record type
Company raise
Stage
Reported raised
Amount raised
$10.1M
Filing date
Sep 4, 2026
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Pharmaceuticals
Number of investors
45
Includes non-accredited investors
Yes
Revenue range
Decline to Disclose
Total offering amount
Indefinite
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 10,147,612 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Sep 4, 2026. Details beyond the filing have not been verified.

Tags

USCompanyPharmaceuticals$10M – $100MCompany Raise

Are you associated with Immunophotonics, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record